Interactions between physicians and the pharmaceutical industry: what does the literature say?
about
Interactions between pharmaceutical representatives and doctors in training. A thematic reviewConflict of interest between professional medical societies and industry: a cross-sectional study of Italian medical societies' websitesGPs' attitudes to benzodiazepine and 'Z-drug' prescribing: a barrier to implementation of evidence and guidance on hypnoticsCharacteristics and impact of drug detailing for gabapentinGlobal health philanthropy and institutional relationships: how should conflicts of interest be addressed?Attitudes and Relationship between Physicians and the Pharmaceutical Industry in a Public General Hospital in Lima, PeruA cross-sectional evidence-based review of pharmaceutical promotional marketing brochures and their underlying studies: is what they tell us important and true?Does pharmaceutical advertising affect journal publication about dietary supplements?General practitioners' continuing education: a review of policies, strategies and effectiveness, and their implications for the future.Who pays for the pizza? Redefining the relationships between doctors and drug companies. 1: entanglement.Attitudes of medical students towards incentives offered by pharmaceutical companies -- perspective from a developing nation -- a cross-sectional study.The association between money and opinion in academic emergency medicine.Bioethics for clinicians: 17. Conflict of interest in research, education and patient careSelling drugs to doctors--it's marketing, not educationSelling drugs to the public--should the UK follow the example of the US?Interactions with the pharmaceutical industry: a survey of family medicine residents in Ontario.Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns and clerksA comparison of physicians' and patients' attitudes toward pharmaceutical industry giftsPharmacists' and physicians' perception and exposure to drug promotion: A Saudi study.Knowledge and perceptions of physicians from private medical centres towards generic medicines: a nationwide survey from Malaysia.Not for industry only: medical students and office-based academic detailing the PIVOT (Pregnant women Influenza Vaccine Optimization Team) initiative.Three years of antibacterial consumption in Indonesian Community Health Centers: The application of anatomical therapeutic chemical/defined daily doses and drug utilization 90% method to monitor antibacterial usePhysicians and drug representatives: exploring the dynamics of the relationshipPharmaceutical industry gifts to physicians: patient beliefs and trust in physicians and the health care systemCME and the pharmaceutical industry: two worlds, three views, four steps."We can't get along without each other": Qualitative interviews with physicians about device industry representatives, conflict of interest and patient safety.Medical Schools' Industry Interaction Policies Not Associated With Trainees' Self-Reported Behavior as Residents: Results of a National Survey.Adding or switching antipsychotic medications in treatment-refractory schizophrenia.Professionalism perspectives among medical students of a novel medical graduate school in Malaysia.Interactions between physicians and pharmaceutical sales representatives in Saudi Arabia.Structured approach to pharmaceutical representatives. Family medicine residency programPoint-counterpoint: should physicians accept gifts from their patients? Yes: If they are given out of beneficence or appreciation.Interactions between physicians and the pharmaceutical industry generally and sales representatives specifically and their association with physicians' attitudes and prescribing habits: a systematic review.Effect of drug sample removal on prescribing in a family practice clinic.Reasons for not seeing drug representatives.Doctors' education: the invisible influence of drug company sponsorship.Legal aspects of the physician-patient relationship. Considerations during health care reform in Canada.Determining an ethical stance. Pharmaceutical industry involvement and family medicine residency training.Technical issues and conservation conditions of medicines in the primary health care of the Brazilian Unified Health System.Multiple constraints compromise decision-making about implantable medical devices for individual patients: qualitative interviews with physicians.
P2860
Q24549713-A646C6AC-DA8C-4F61-A6F8-38508EEF614BQ24658534-206E4D9A-2D9C-4F23-880D-503E969264D0Q24683948-34ECA525-0A07-41BC-9144-E93D0C83B652Q28469192-91C1AE1B-576C-492B-966E-8103FA2C1589Q28741208-121F2883-CDF2-41B1-B8E9-F6F817DF1E98Q28972252-F1DD3E7F-FBC3-49D3-949F-3A8237A7C101Q33235413-FF787ACF-0404-488C-BCD9-9511B09F369EQ33327425-7DA02E95-D4DF-4C32-8A58-C642C8029007Q33539909-35B0C1A5-0F14-4600-8D74-9859E40FAD5AQ33815142-E4C654D4-1928-4BBD-B90B-0450B6D0277DQ33914201-437F1991-A5DA-416F-8F4B-364E8B8BC878Q34014179-86809D51-F641-4BE1-AC0B-E82A24795C89Q34029847-C49AB079-121C-4C1C-B3D2-F9F88000CC3BQ34221308-5A24FFB1-A873-454E-B5C5-E75981039856Q34221314-202B4589-5A18-46FE-929D-9C3D65587559Q34272030-EC2865C9-7256-47F2-A688-619BD1DDF8EEQ34710244-F844C046-5457-492B-8201-9CCC966CBE10Q34751748-5F41E7E1-2067-4B1D-A37F-67C7C246DC8EQ34800209-A1C9B219-2720-41C2-AFF5-EB8863D87EFCQ35224195-FED72C63-AC9A-4FC8-B6CD-4DBC2191884AQ35494163-2EF10643-E432-4E64-8628-0C2C95B6A02FQ35555427-E846C85E-F70B-4B84-8A6A-816C5D5C8475Q35683129-34E0C6A2-1FE1-436E-8135-D4FFF5646A21Q35777666-A23D6D9C-ED72-43C6-A214-2AC83F6DF7D1Q35855628-BF1C8270-B6FE-4701-AFB4-2CD53EAC7B7DQ36328375-0DD34603-52CB-4CD6-B216-825A7A3BC4AEQ36362502-ABC475F6-02AC-4299-A22A-8DBAF47EB25BQ36905070-B37A1D7A-1E7C-4A8B-ADCA-83B5CC8A1FB9Q37138525-2711A965-C958-4299-84FA-58812CCEEEEEQ39274618-474FDBD5-84A6-462C-9465-3D6D8877288EQ40856816-14A49A1A-5190-4ACC-AA42-94A4CB3ACF03Q41972977-58079EAD-4267-437A-ACB2-CA0A4C33D008Q42215595-935D1967-21E9-40A6-9C6D-C1A0A1984F2EQ42426725-BEB007F2-26A5-4CD2-9F1C-1721733025FFQ42763354-02298F9B-EFE8-4141-9724-6FEAFD66ECBBQ43054337-A365F5A2-3E57-49F6-890D-8EF1D1D6D6EDQ43059844-9B84D50A-0CFA-459E-9FB0-D1CC7A0BE4B2Q43059959-6A7E75D6-AF96-40DA-A85D-FDAFC4C96112Q45238575-2C12BEAB-77A3-49E4-B841-38CE14DD1D08Q47112540-FF7E8B44-DA55-4CAC-B2FD-EBB762221122
P2860
Interactions between physicians and the pharmaceutical industry: what does the literature say?
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Interactions between physician ...... what does the literature say?
@en
type
label
Interactions between physician ...... what does the literature say?
@en
prefLabel
Interactions between physician ...... what does the literature say?
@en
P2860
P1476
Interactions between physician ...... what does the literature say?
@en
P2093
P2860
P304
P407
P577
1993-11-01T00:00:00Z